View in EDS HTML Full Text PDF Full Text

Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.

Saved in:
Bibliographic Details
Title: Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
Authors: Pennington, Thomas E1,2,3 (AUTHOR) thomas.pennington@melanoma.org.au, Zhao, Cathy Yunjia4 (AUTHOR), Colebatch, Andrew J1,2,3,5,6 (AUTHOR), Fernandez‐Peñas, Pablo2,4 (AUTHOR), Guitera, Pascale1,2,3 (AUTHOR), Burke, Hazel1 (AUTHOR), Scolyer, Richard A1,2,5,6 (AUTHOR), Menzies, Alexander M1,2,7 (AUTHOR), Carlino, Matteo S1,2,4 (AUTHOR), Lo, Serigne1,2 (AUTHOR), Long, Georgina V1,2,7 (AUTHOR), Saw, Robyn PM1,2,3 (AUTHOR)
Source: Australasian Journal of Dermatology. May2022, Vol. 63 Issue 2, pe133-e137. 5p. 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00048380
DOI:10.1111/ajd.13807